Notice of Proposed Sale · 144
Immunocore Holdings PLC
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Immunocore Holdings PLC
- Issuer CIK
- 0001671927
- Phone
- 441235438600
- Person for whose account securities are to be sold
- David Berman
- Relationships to issuer
- Affiliate
- Street
- 92 Park Drive Milton Park
- City
- Oxfordshire
- State / country code
- X0
- Postal code
- OX14 4 RY
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| ADR | 69,271 | 2,042,147.94 | 50,387,068 | 05/22/2026 | NASDAQ | J.P. Morgan Securities LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- J.P. Morgan Securities LLC
- Street
- 270 Park Ave
- Street (continued)
- 10th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10017
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| ADR | 05/22/2026 | Same Day Cashless Exercise and Sale | Immunocore Holdings Plc (issuer) | 69,271 | N | 05/26/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| David Berman | ADR | 03/11/2026 | 11,832 | 385,330.11 |
| David Berman | ADR | 04/08/2026 | 25,000 | 798,510.57 |
| David Berman | ADR | 05/21/2026 | 65,000 | 1,894,638.32 |
Seller — prior-sale row 1, entry 1
- Name
- David Berman
- Street
- 4915 Hampden Ln
- Street (continued)
- Unit 405
- City
- Bethesda
- State / country code
- MD
- Postal code
- 20814
Seller — prior-sale row 2, entry 1
- Name
- David Berman
- Street
- 4915 Hampden Ln
- Street (continued)
- Unit 405
- City
- Bethesda
- State / country code
- MD
- Postal code
- 20814
Seller — prior-sale row 3, entry 1
- Name
- David Berman
- Street
- 4915 Hampden Ln
- Street (continued)
- Unit 405
- City
- Bethesda
- State / country code
- MD
- Postal code
- 20814
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 05/22/2026
- Signed
- J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for David Berman, Immunocore Holdings PLC
Company context
Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX - Immune mobilizing monoclonal TCRs Against X disease - designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including clinical and pre-clinical programs in oncology, infectious diseases, and autoimmune diseases. The Company’s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.